Less Ads, More Data, More Tools Register for FREE

Pin to quick picksClose Bros Regulatory News (CBG)

Share Price Information for Close Bros (CBG)

Share Price is delayed by 15 minutes
Get Live Data
407.00    0.80 (0.20%)
Bid:
405.00
Ask:
405.40
Spread: 0.40 (0.099%)
Market Cap: £613.40m
CBG Live PriceLast checked at - London Stock Exchange

Intraday Close Bros Share Chart

Scheduled Trading Update

22 Jan 2019 07:00

RNS Number : 6874N
Close Brothers Group PLC
22 January 2019
 

 

Scheduled Trading Update

Close Brothers Group plc ("the group" or "Close Brothers") today issues its scheduled pre-close trading update ahead of its 2019 half year end. Close Brothers will be releasing its half year results for the six months ending 31 January 2019 on 12 March 2019.

All statements in this release relate to continuing operations1 over the five months to 31 December 2018 unless otherwise indicated.

Group and divisional performance

The group has achieved a solid performance overall, notwithstanding the difficult trading conditions for our market facing businesses.

The Banking division has continued to perform well and in line with expectations, as we focus on maintaining our disciplined approach to lending and investing to maximise the long-term potential of our businesses.

The loan book grew 3.1% in the period to £7.5 billion (1 August 2018: £7.2 billion2), driven by good new business volumes across the Commercial businesses and in Premium Finance.

Impairment charges remained low, with strong credit performance across all businesses. The net interest margin has remained broadly stable since the last financial year, reflecting our continued pricing discipline.

Winterflood has continued to deliver solid profitability, but volumes and trading income have been significantly lower than the prior year reflecting difficult and volatile equity market conditions, particularly in December.

Asset Management has continued to achieve good net inflows, although these were more than offset by negative market movements, resulting in a 3% decline in managed assets to £10.0 billion at 31 December 2018 (31 July 2018: £10.4 billion) and a decrease in total client assets to £11.7 billion (31 July 2018: £12.2 billion).

Outlook

Overall, we expect a solid outcome for the first half, and remain well positioned for the remainder of the financial year.

 

1 Results from continuing operations exclude the unsecured retail point of sale finance business, which was classified as a discontinued operation in the group's 2018 financial statements.

2 The opening net loan book of £7,239 million reflects the adoption of IFRS 9 at 1 August 2018. For further details see the group's IFRS 9 transition document published on 7 November 2018.

 

 

Enquiries

 

Sophie Gillingham

Close Brothers Group plc

020 7655 3844

Matt Bullivant

Close Brothers Group plc

020 7655 3698

Declan Simpson

Close Brothers Group plc

020 7655 3632

Andy Donald

Maitland

020 7379 5151

 

About Close Brothers

Close Brothers is a leading UK merchant banking group providing lending, deposit taking, wealth management services and securities trading. We employ around 3,300 people, principally in the UK. Close Brothers Group plc is listed on the London Stock Exchange and is a member of the FTSE 250.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTCKDDPABKDNDB
Date   Source Headline
4th Sep 20174:27 pmRNSTransaction in Own Shares
31st Aug 20174:30 pmRNSTotal Voting Rights
30th Aug 20173:12 pmRNSHolding(s) in Company
25th Aug 201711:34 amRNSHolding(s) in Company
21st Aug 20173:08 pmRNSTransaction in Own Shares
17th Aug 20173:35 pmRNSHolding(s) in Company
8th Aug 20171:15 pmRNSDirector/PDMR Shareholding
7th Aug 20172:29 pmRNSTransaction in Own Shares
3rd Aug 201710:06 amRNSHolding(s) in Company
31st Jul 20174:11 pmRNSHolding(s) in Company
31st Jul 20173:34 pmRNSTotal Voting Rights
31st Jul 20173:02 pmRNSTransaction in Own Shares
24th Jul 20172:29 pmRNSTransaction in Own Shares
21st Jul 20177:00 amRNSScheduled Trading Update
10th Jul 20172:30 pmRNSTransaction in Own Shares
7th Jul 20175:04 pmRNSHolding(s) in Company
7th Jul 20172:38 pmRNSDirector/PDMR Shareholding
7th Jul 20172:34 pmRNSDirector/PDMR Shareholding
3rd Jul 20174:08 pmRNSTransaction in Own Shares
30th Jun 20174:06 pmRNSTotal Voting Rights
26th Jun 20174:24 pmRNSTransaction in Own Shares
21st Jun 201711:15 amRNSNotice of Pre-Close Trading Update
19th Jun 20175:24 pmRNSTransaction in Own Shares
14th Jun 20174:08 pmRNSDirector/PDMR Shareholding
12th Jun 20174:41 pmRNSDirector/PDMR Shareholding
12th Jun 20174:28 pmRNSTransaction in Own Shares
6th Jun 20176:12 pmRNSDirector/PDMR Shareholding
5th Jun 20175:36 pmRNSTransaction in Own Shares
1st Jun 20175:05 pmRNSTransaction in Own Shares
1st Jun 201712:03 pmRNSTotal Voting Rights
30th May 20175:46 pmRNSTransaction in Own Shares
25th May 20174:37 pmRNSCompany Secretary Change
22nd May 20173:08 pmRNSTransaction in Own Shares
19th May 201711:00 amRNSChange of auditor
19th May 20177:00 amRNSScheduled Trading Update
16th May 201711:30 amRNSTransaction in Own Shares
15th May 20172:56 pmRNSHolding(s) in Company
11th May 201712:38 pmRNSChange in Director's Details
10th May 201711:59 amRNSDirector/PDMR Shareholding
8th May 20172:46 pmRNSTransaction in Own Shares
8th May 20171:40 pmRNSDirector/PDMR Shareholding
4th May 201710:51 amRNSDirector/PDMR Shareholding
4th May 20177:00 amRNSAdditional Listing
2nd May 20174:50 pmRNSTransaction in Own Shares
2nd May 201710:11 amRNSHolding(s) in Company
28th Apr 20174:31 pmRNSTotal Voting Rights
28th Apr 20174:31 pmRNSBlock listing Interim Review
27th Apr 20174:25 pmRNSDirector/PDMR Shareholding
25th Apr 20174:37 pmRNSDirector/PDMR Shareholding
24th Apr 201711:28 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.